Pharma Sequencing Opportunity LC Sciences offers the VariantPro multiplex-PCR targeted sequencing system along with OligoMix library construction and OligoFix error correction for synthetic biology. This combination positions LC Sciences as a cost-efficient partner for pharma and biotech firms pursuing targeted panels, library preparation outsourcing, and rapid assay development, backed by their demonstrated pharma collaboration.

Custom Microarray Outsourcing The µParaflo microfluidic on-chip synthesis platform enables customizable arrays of oligos and peptides, with services including microRNA profiling, aptamer screening, and epitope mapping. This creates opportunities to engage CROs and biotech startups needing tailored arrays for biomarker discovery, diagnostics, and drug screening through end-to-end or co-developed assays.

Growth SMB Potential With a small to mid-sized workforce and service-based offerings, LC Sciences is well positioned to partner with growing academic labs and early-stage biotech firms seeking scalable outsourcing of sequencing, library prep, and microarray services on flexible pricing and project-based arrangements.

Global Partnerships LC Sciences has established pharma collaborations and a global presence, providing a pathway for co-marketing, joint development, or distribution partnerships to expand into new markets and customer segments in genomics, proteomics, and synthetic biology services.

Case Study Value Public collaborations and cross-industry applications, such as work with AstraZeneca and Nano3D, offer tangible case studies to validate value for potential customers. Leverage these references to secure pilots in pharma and biotech R&D teams.